Titan Medical Inc (TMDIF)

[drmacd]

Looking at TRXC news releases and developments you can see that it will be a very bumpy ride thru approvals and roll outs. TRXC was refused on their bot application but was approved later for their Senhance application.

Their SP dropped a lot AFTER FDA approval since ivnestors now started to focus on actual costs to roll out. Spending $50M/a to get mods approved, roll out SLOWLY their equipment to hospitals and universities. Revenue of $24M in the first year is equipment sales with low margins. Royalties will follow in the coming years, but they have an open prospectus for another $75M if they need cash. Hence my point is that it is WAY too early to be talking about LOANS vs share capital.

The surprise here was the valuation of AURIS since it makes ZERO sense. J&J could have spent far less. The strength of AURIS was their high cash position and hence they were on solid ground to go commercial and be a player. Titan is on shaky footing in terms of cash position and has no white knight to give them deep pockets.

I believe there is great potential here but investors are very uninformed about the prospects in terms of probabilities. Perhaps the technology here is vastly superior but there is a tale of two stories here with AURIS and TRXC ... which one TMDI will follow is hard to say but our SP is more closely following TRXC than AURIS.

I will buy eventually but not at current prices. Otherwise I will wait for FDA approval and buy in 12 months after the roll out. The SP will be much lower than when reality kicks in. The best hope for a big payout in the near term is a BUYOUT and if that happens then good on the many PUMPERS on this board who seem to not know much about the progression of these med techs.

Hopeful optimism is high on this board.